BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 25
• 26
• 27
• 28
• 29

• Business

  Global Blood Therapeutics Announces Appointment Of Jeffrey Farrow As CFO

  April 4, 2016

   · 

  4 min read
• Drug Development

  CytRx Global Pivotal Phase 3 Clinical Trial With Aldoxorubicin Achieves 191 Target Events Triggering Statistical Data Analysis

  April 4, 2016

   · 

  6 min read
• Deals

  ANI Pharma Closes Acquisition Of Inderal LA Assets

  April 4, 2016

   · 

  3 min read
• Drug Development

  ORYZON Genomics Announces First Subject Dosed In Phase I Healthy Volunteer Study Evaluating Oral Epigenetic Drug ORY-2001 For Alzheimer’s Disease

  April 4, 2016

   · 

  5 min read
• BioMidwest

  Edwards Lifesciences SAPIEN 3 TAVR Demonstrates Clinical Superiority To Surgery In PARTNER II Study

  April 4, 2016

   · 

  5 min read
• Drug Development

  Janssen Release: Real-World Study Further Confirms Safety Profile Of XARELTO In Nearly 45,000 People With Non-Valvular Atrial Fibrillation (NVAF), Including Those With Concomitant Diabetes

  April 4, 2016

   · 

  15 min read
• Biotech Bay

  Vantage Oncology And Vantage Oncology Finance Co. Announce Change Of Control Offer To Purchase 9.500% Senior Secured Notes Due 2017

  April 4, 2016

   · 

  4 min read
• Business

  Oxford BioTherapeutics Licenses Nerviano Medical Sciences (NervianoMS)’ Drug-Linker Technology To Develop Novel Antibody Drug Conjugates

  April 4, 2016

   · 

  4 min read
• Drug Development

  Biomarker Analyses Of Neuraltus Pharmaceuticals, Inc.’ NP001 Phase 2 Data Demonstrate Potential For Treating ALS Patients With Systemic Inflammation

  April 4, 2016

   · 

  5 min read
• Business

  Innophos Holdings, Inc. Appoints Han Kieftenbeld As Chief Financial Officer

  April 4, 2016

   · 

  4 min read